Clinical Trials Directory

Trials / Unknown

UnknownNCT04222361

KDIGO Bundle to Prevent AKI in Sepsis

Prevention of Acute Renal Injury in the Septic Patient by Implementing the KDIGO Guideline in High-risk Patients Identified by Biomarkers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Summary: Controlled, prospective, randomized and randomized clinical trial of two intervention groups (standard care vs. preventive recommendations the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI) of patients diagnosed with sepsis and abdominal post-surgical septic shock with positive results in the risk determination of acute renal injury by NephroCheck® Test that integrates the urinary biomarkers TIMP-2 and IGFBP-7. Hypothesis: The implementation of a package of preventive measures proposed by the KDIGO guide can reduce the occurrence and severity of acute renal injury in the high-risk abdominal post-surgical septic patient detected by urinary biomarkers for early detection.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreventive recommendations for kidney disease: guidelines for improving overall outcomes (KDIGO) for AKIPatients assigned to the treatment group will receive the AKI preventive recommendations from the KDIGO guide: withdraw nephrotoxics, ensure volemia and renal perfusion pressure by means of advanced hemodynamic monitoring-optimization (minimum monitoring objective: Unit algorithm based on volume systolic (VS) by pulse wave analysis - Flotrac® / ClearSight® system - or transpulmonary thermodilution - VolumeView® system -), monitor plasma creatinine and urinary expenditure, avoid hyperglycemia (serum blood glucose target: 110-149 mg / dl), and consider alternatives to diagnostic-therapeutic radiocontrast procedures.

Timeline

Start date
2020-10-01
Primary completion
2022-06-01
Completion
2022-11-01
First posted
2020-01-10
Last updated
2020-07-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04222361. Inclusion in this directory is not an endorsement.